StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck employee Training — Total Training Hours (millions)

Merck Impact Report

Latest, FY2025
3.00
Period ended Dec 31, 2025
Change on a year earlier
-6.2%
3.20 in FY2024
History
8 years
Since FY2018
Sources
1
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEmployee Training — Total Training Hours (millions)Year on yearSource
FY2025Dec 31, 20253.00-6.2%–
FY2024Dec 31, 20243.20+18.5%–
FY2023Dec 31, 20232.70+8.0%–
FY2022Dec 31, 20222.50-21.9%–
FY2021Dec 31, 20213.20-11.1%–
FY2020Dec 31, 20203.60+33.3%–
FY2019Dec 31, 20192.70+35.0%–
FY2018Dec 31, 20182.00––

Cite this data

StockData. (2026). Merck Employee Training — Total Training Hours (millions), annual FY2018–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/hr_train_hours_m

See every metric in the Merck KPI table. Data updated Oct 26, 2026.